Vaccines Market Size, Top Share, Global Trends And Report By 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Vaccines Market Size Analysis

Global Vaccines Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Monovalent
  1. By Value
3. Multivalent
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Nasal
  1. By Value
By Disease Indication
1. Introduction
  1. Disease Indication By Value
2. Viral
  1. By Value
  2. Hepatitis Vaccine
    1. Hepatitis Vaccine By Value
  3. Influenza Vaccine
    1. Influenza Vaccine By Value
  4. Human Papillomavirus (HPV) Vaccine
    1. Human Papillomavirus (HPV) Vaccine By Value
  5. Rotavirus Vaccine (RV)
    1. Rotavirus Vaccine (RV) By Value
  6. Polio Vaccine
    1. Polio Vaccine By Value
  7. Varicella Vaccine
    1. Varicella Vaccine By Value
  8. COVID-19 Vaccine
    1. COVID-19 Vaccine By Value
  9. Measles, Mumps and Rubella (MMR) Vaccine
    1. Measles, Mumps and Rubella (MMR) Vaccine By Value
  10. Other Vaccines
    1. Other Vaccines By Value
3. Bacterial
  1. By Value
  2. Pneumococcal Conjugate Vaccine (PCV)
    1. Pneumococcal Conjugate Vaccine (PCV) By Value
  3. Meningococcal Vaccine
    1. Meningococcal Vaccine By Value
  4. Diphtheria, Tetanus, and Pertussis Vaccines
    1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
  5. Other Vaccines
    1. Other Vaccines By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Pediatric
  1. By Value
3. Adult
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Monovalent
  1. By Value
3. Multivalent
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Nasal
  1. By Value
By Disease Indication
1. Introduction
  1. Disease Indication By Value
2. Viral
  1. By Value
  2. Hepatitis Vaccine
    1. Hepatitis Vaccine By Value
  3. Influenza Vaccine
    1. Influenza Vaccine By Value
  4. Human Papillomavirus (HPV) Vaccine
    1. Human Papillomavirus (HPV) Vaccine By Value
  5. Rotavirus Vaccine (RV)
    1. Rotavirus Vaccine (RV) By Value
  6. Polio Vaccine
    1. Polio Vaccine By Value
  7. Varicella Vaccine
    1. Varicella Vaccine By Value
  8. COVID-19 Vaccine
    1. COVID-19 Vaccine By Value
  9. Measles, Mumps and Rubella (MMR) Vaccine
    1. Measles, Mumps and Rubella (MMR) Vaccine By Value
  10. Other Vaccines
    1. Other Vaccines By Value
3. Bacterial
  1. By Value
  2. Pneumococcal Conjugate Vaccine (PCV)
    1. Pneumococcal Conjugate Vaccine (PCV) By Value
  3. Meningococcal Vaccine
    1. Meningococcal Vaccine By Value
  4. Diphtheria, Tetanus, and Pertussis Vaccines
    1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
  5. Other Vaccines
    1. Other Vaccines By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Pediatric
  1. By Value
3. Adult
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Monovalent
    1. By Value
  3. Multivalent
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Nasal
    1. By Value
3. By Disease Indication
  1. Introduction
    1. Disease Indication By Value
  2. Viral
    1. By Value
    2. Hepatitis Vaccine
      1. Hepatitis Vaccine By Value
    3. Influenza Vaccine
      1. Influenza Vaccine By Value
    4. Human Papillomavirus (HPV) Vaccine
      1. Human Papillomavirus (HPV) Vaccine By Value
    5. Rotavirus Vaccine (RV)
      1. Rotavirus Vaccine (RV) By Value
    6. Polio Vaccine
      1. Polio Vaccine By Value
    7. Varicella Vaccine
      1. Varicella Vaccine By Value
    8. COVID-19 Vaccine
      1. COVID-19 Vaccine By Value
    9. Measles, Mumps and Rubella (MMR) Vaccine
      1. Measles, Mumps and Rubella (MMR) Vaccine By Value
    10. Other Vaccines
      1. Other Vaccines By Value
  3. Bacterial
    1. By Value
    2. Pneumococcal Conjugate Vaccine (PCV)
      1. Pneumococcal Conjugate Vaccine (PCV) By Value
    3. Meningococcal Vaccine
      1. Meningococcal Vaccine By Value
    4. Diphtheria, Tetanus, and Pertussis Vaccines
      1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
    5. Other Vaccines
      1. Other Vaccines By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Pediatric
    1. By Value
  3. Adult
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Monovalent
  1. By Value
3. Multivalent
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Nasal
  1. By Value
By Disease Indication
1. Introduction
  1. Disease Indication By Value
2. Viral
  1. By Value
  2. Hepatitis Vaccine
    1. Hepatitis Vaccine By Value
  3. Influenza Vaccine
    1. Influenza Vaccine By Value
  4. Human Papillomavirus (HPV) Vaccine
    1. Human Papillomavirus (HPV) Vaccine By Value
  5. Rotavirus Vaccine (RV)
    1. Rotavirus Vaccine (RV) By Value
  6. Polio Vaccine
    1. Polio Vaccine By Value
  7. Varicella Vaccine
    1. Varicella Vaccine By Value
  8. COVID-19 Vaccine
    1. COVID-19 Vaccine By Value
  9. Measles, Mumps and Rubella (MMR) Vaccine
    1. Measles, Mumps and Rubella (MMR) Vaccine By Value
  10. Other Vaccines
    1. Other Vaccines By Value
3. Bacterial
  1. By Value
  2. Pneumococcal Conjugate Vaccine (PCV)
    1. Pneumococcal Conjugate Vaccine (PCV) By Value
  3. Meningococcal Vaccine
    1. Meningococcal Vaccine By Value
  4. Diphtheria, Tetanus, and Pertussis Vaccines
    1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
  5. Other Vaccines
    1. Other Vaccines By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Pediatric
  1. By Value
3. Adult
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Monovalent
    1. By Value
  3. Multivalent
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Nasal
    1. By Value
3. By Disease Indication
  1. Introduction
    1. Disease Indication By Value
  2. Viral
    1. By Value
    2. Hepatitis Vaccine
      1. Hepatitis Vaccine By Value
    3. Influenza Vaccine
      1. Influenza Vaccine By Value
    4. Human Papillomavirus (HPV) Vaccine
      1. Human Papillomavirus (HPV) Vaccine By Value
    5. Rotavirus Vaccine (RV)
      1. Rotavirus Vaccine (RV) By Value
    6. Polio Vaccine
      1. Polio Vaccine By Value
    7. Varicella Vaccine
      1. Varicella Vaccine By Value
    8. COVID-19 Vaccine
      1. COVID-19 Vaccine By Value
    9. Measles, Mumps and Rubella (MMR) Vaccine
      1. Measles, Mumps and Rubella (MMR) Vaccine By Value
    10. Other Vaccines
      1. Other Vaccines By Value
  3. Bacterial
    1. By Value
    2. Pneumococcal Conjugate Vaccine (PCV)
      1. Pneumococcal Conjugate Vaccine (PCV) By Value
    3. Meningococcal Vaccine
      1. Meningococcal Vaccine By Value
    4. Diphtheria, Tetanus, and Pertussis Vaccines
      1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
    5. Other Vaccines
      1. Other Vaccines By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Pediatric
    1. By Value
  3. Adult
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Monovalent
  1. By Value
3. Multivalent
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Nasal
  1. By Value
By Disease Indication
1. Introduction
  1. Disease Indication By Value
2. Viral
  1. By Value
  2. Hepatitis Vaccine
    1. Hepatitis Vaccine By Value
  3. Influenza Vaccine
    1. Influenza Vaccine By Value
  4. Human Papillomavirus (HPV) Vaccine
    1. Human Papillomavirus (HPV) Vaccine By Value
  5. Rotavirus Vaccine (RV)
    1. Rotavirus Vaccine (RV) By Value
  6. Polio Vaccine
    1. Polio Vaccine By Value
  7. Varicella Vaccine
    1. Varicella Vaccine By Value
  8. COVID-19 Vaccine
    1. COVID-19 Vaccine By Value
  9. Measles, Mumps and Rubella (MMR) Vaccine
    1. Measles, Mumps and Rubella (MMR) Vaccine By Value
  10. Other Vaccines
    1. Other Vaccines By Value
3. Bacterial
  1. By Value
  2. Pneumococcal Conjugate Vaccine (PCV)
    1. Pneumococcal Conjugate Vaccine (PCV) By Value
  3. Meningococcal Vaccine
    1. Meningococcal Vaccine By Value
  4. Diphtheria, Tetanus, and Pertussis Vaccines
    1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
  5. Other Vaccines
    1. Other Vaccines By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Pediatric
  1. By Value
3. Adult
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Monovalent
    1. By Value
  3. Multivalent
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Nasal
    1. By Value
3. By Disease Indication
  1. Introduction
    1. Disease Indication By Value
  2. Viral
    1. By Value
    2. Hepatitis Vaccine
      1. Hepatitis Vaccine By Value
    3. Influenza Vaccine
      1. Influenza Vaccine By Value
    4. Human Papillomavirus (HPV) Vaccine
      1. Human Papillomavirus (HPV) Vaccine By Value
    5. Rotavirus Vaccine (RV)
      1. Rotavirus Vaccine (RV) By Value
    6. Polio Vaccine
      1. Polio Vaccine By Value
    7. Varicella Vaccine
      1. Varicella Vaccine By Value
    8. COVID-19 Vaccine
      1. COVID-19 Vaccine By Value
    9. Measles, Mumps and Rubella (MMR) Vaccine
      1. Measles, Mumps and Rubella (MMR) Vaccine By Value
    10. Other Vaccines
      1. Other Vaccines By Value
  3. Bacterial
    1. By Value
    2. Pneumococcal Conjugate Vaccine (PCV)
      1. Pneumococcal Conjugate Vaccine (PCV) By Value
    3. Meningococcal Vaccine
      1. Meningococcal Vaccine By Value
    4. Diphtheria, Tetanus, and Pertussis Vaccines
      1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
    5. Other Vaccines
      1. Other Vaccines By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Pediatric
    1. By Value
  3. Adult
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Monovalent
  1. By Value
3. Multivalent
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Nasal
  1. By Value
By Disease Indication
1. Introduction
  1. Disease Indication By Value
2. Viral
  1. By Value
  2. Hepatitis Vaccine
    1. Hepatitis Vaccine By Value
  3. Influenza Vaccine
    1. Influenza Vaccine By Value
  4. Human Papillomavirus (HPV) Vaccine
    1. Human Papillomavirus (HPV) Vaccine By Value
  5. Rotavirus Vaccine (RV)
    1. Rotavirus Vaccine (RV) By Value
  6. Polio Vaccine
    1. Polio Vaccine By Value
  7. Varicella Vaccine
    1. Varicella Vaccine By Value
  8. COVID-19 Vaccine
    1. COVID-19 Vaccine By Value
  9. Measles, Mumps and Rubella (MMR) Vaccine
    1. Measles, Mumps and Rubella (MMR) Vaccine By Value
  10. Other Vaccines
    1. Other Vaccines By Value
3. Bacterial
  1. By Value
  2. Pneumococcal Conjugate Vaccine (PCV)
    1. Pneumococcal Conjugate Vaccine (PCV) By Value
  3. Meningococcal Vaccine
    1. Meningococcal Vaccine By Value
  4. Diphtheria, Tetanus, and Pertussis Vaccines
    1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
  5. Other Vaccines
    1. Other Vaccines By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Pediatric
  1. By Value
3. Adult
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Monovalent
    1. By Value
  3. Multivalent
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Nasal
    1. By Value
3. By Disease Indication
  1. Introduction
    1. Disease Indication By Value
  2. Viral
    1. By Value
    2. Hepatitis Vaccine
      1. Hepatitis Vaccine By Value
    3. Influenza Vaccine
      1. Influenza Vaccine By Value
    4. Human Papillomavirus (HPV) Vaccine
      1. Human Papillomavirus (HPV) Vaccine By Value
    5. Rotavirus Vaccine (RV)
      1. Rotavirus Vaccine (RV) By Value
    6. Polio Vaccine
      1. Polio Vaccine By Value
    7. Varicella Vaccine
      1. Varicella Vaccine By Value
    8. COVID-19 Vaccine
      1. COVID-19 Vaccine By Value
    9. Measles, Mumps and Rubella (MMR) Vaccine
      1. Measles, Mumps and Rubella (MMR) Vaccine By Value
    10. Other Vaccines
      1. Other Vaccines By Value
  3. Bacterial
    1. By Value
    2. Pneumococcal Conjugate Vaccine (PCV)
      1. Pneumococcal Conjugate Vaccine (PCV) By Value
    3. Meningococcal Vaccine
      1. Meningococcal Vaccine By Value
    4. Diphtheria, Tetanus, and Pertussis Vaccines
      1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
    5. Other Vaccines
      1. Other Vaccines By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Pediatric
    1. By Value
  3. Adult
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Monovalent
  1. By Value
3. Multivalent
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Nasal
  1. By Value
By Disease Indication
1. Introduction
  1. Disease Indication By Value
2. Viral
  1. By Value
  2. Hepatitis Vaccine
    1. Hepatitis Vaccine By Value
  3. Influenza Vaccine
    1. Influenza Vaccine By Value
  4. Human Papillomavirus (HPV) Vaccine
    1. Human Papillomavirus (HPV) Vaccine By Value
  5. Rotavirus Vaccine (RV)
    1. Rotavirus Vaccine (RV) By Value
  6. Polio Vaccine
    1. Polio Vaccine By Value
  7. Varicella Vaccine
    1. Varicella Vaccine By Value
  8. COVID-19 Vaccine
    1. COVID-19 Vaccine By Value
  9. Measles, Mumps and Rubella (MMR) Vaccine
    1. Measles, Mumps and Rubella (MMR) Vaccine By Value
  10. Other Vaccines
    1. Other Vaccines By Value
3. Bacterial
  1. By Value
  2. Pneumococcal Conjugate Vaccine (PCV)
    1. Pneumococcal Conjugate Vaccine (PCV) By Value
  3. Meningococcal Vaccine
    1. Meningococcal Vaccine By Value
  4. Diphtheria, Tetanus, and Pertussis Vaccines
    1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
  5. Other Vaccines
    1. Other Vaccines By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Pediatric
  1. By Value
3. Adult
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Monovalent
    1. By Value
  3. Multivalent
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Nasal
    1. By Value
3. By Disease Indication
  1. Introduction
    1. Disease Indication By Value
  2. Viral
    1. By Value
    2. Hepatitis Vaccine
      1. Hepatitis Vaccine By Value
    3. Influenza Vaccine
      1. Influenza Vaccine By Value
    4. Human Papillomavirus (HPV) Vaccine
      1. Human Papillomavirus (HPV) Vaccine By Value
    5. Rotavirus Vaccine (RV)
      1. Rotavirus Vaccine (RV) By Value
    6. Polio Vaccine
      1. Polio Vaccine By Value
    7. Varicella Vaccine
      1. Varicella Vaccine By Value
    8. COVID-19 Vaccine
      1. COVID-19 Vaccine By Value
    9. Measles, Mumps and Rubella (MMR) Vaccine
      1. Measles, Mumps and Rubella (MMR) Vaccine By Value
    10. Other Vaccines
      1. Other Vaccines By Value
  3. Bacterial
    1. By Value
    2. Pneumococcal Conjugate Vaccine (PCV)
      1. Pneumococcal Conjugate Vaccine (PCV) By Value
    3. Meningococcal Vaccine
      1. Meningococcal Vaccine By Value
    4. Diphtheria, Tetanus, and Pertussis Vaccines
      1. Diphtheria, Tetanus, and Pertussis Vaccines By Value
    5. Other Vaccines
      1. Other Vaccines By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Pediatric
    1. By Value
  3. Adult
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Vaccines Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Pfizer Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Moderna, Inc.
Merck & Co., Inc.
GSK plc
Sanofi
BioNTech SE.
Johnson & Johnson
China National Biotec Group Company Limited (CNBG)
AstraZeneca
Serum Institute of India (SII)
Bejing
CSL Behring
Walvax Biotechnology Co., Ltd.
Bavarian Nordic Inc.
Takeda Pharmaceutical Company Limited

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment